SLC2A12 and gastric cancer: found that the expression level of exosomal lnc-SLC2A12-10:1 was significantly correlated with tumor size, TNM stage, lymph node metastasis, and degree of differentiation, suggesting that exosomal lnc-SLC2A12-10:1 may be a potential noninvasive biomarker for the diagnosis and prognosis monitoring of gastric cancer (132).